Clinical trials
Completed Esophageal Squamous Cell Carcinoma trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BeiGene | 4 |
| Hoffmann-La Roche | 3 |
| Merck Sharp & Dohme LLC | 2 |
| Novartis Pharmaceuticals | 2 |
| Samsung Medical Center | 2 |
| Yonsei University | 2 |
| AstraZeneca | 1 |
| Bayer | 1 |
| Exelixis | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 19 |
| Esophageal Neoplasms | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Stomach Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Neoplasm Metastasis | 2 |
| Small Cell Lung Carcinoma | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Astrocytoma | 1 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.